Finally, inhibiting the packaging of B7-H4 into EVs by GBM cells, using GW4869 or B7-H4 shRNA treatment, led to reduced tumour growth and longer survival following irradiation in their in vivo mouse model, with radiation-induced increased B7-H4 leading to radioresistance. This evidence concerns the gene VTCN1 and glioblastoma.